Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05928221 · ClinicalTrials.gov registry record
Post Market Registry Study of the Philips QuickClear Mechanical Thrombectomy System
A clinical trial of Acute Deep Venous Thrombosis of Ileofemoral Vein, sponsored by Paul J. Gagne.
- Active
- Registry status
- 50
- Enrollment target
- 6
- Study locations
NCT05928221: Active study of Acute Deep Venous Thrombosis of Ileofemoral Vein, sponsored by Paul J. Gagne.
NCT05928221 is a study of Acute Deep Venous Thrombosis of Ileofemoral Vein that is active but no longer recruiting, run by Paul J. Gagne. The registered enrollment target is 50 participants. The trial reports 6 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05928221, a study of Acute Deep Venous Thrombosis of Ileofemoral Vein, is active but no longer recruiting, sponsored by Paul J. Gagne.
- ACTIVE NOT RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 6
- Study locations
Study Summary
A post-market study of the QuickClear Mechanical Thrombectomy system used for the removal of acute Deep Vein Thrombosis (DVT) from the deep veins of legs in the setting of an office interventional suite.
Primary Outcome
Extent of acute DVT removal overall and in each segment (Common Iliac Vein (CIV), External Iliac Vein (EIV), Common Femoral Vein (CFV), Profunda Femoris Vein (PFV), Femoral Vein (FV), Popliteal (POP) as measured by IVUS and Venography
Conditions Studied
Interventions
- DEVICE Thrombectomy
Study Locations (6)
Massachusetts
- The Vascular Care Group - Hyannis
- The Vascular Care Group - Leominster
- The Vascular Care Group - Plymouth
- The Vascular Care Group - Wellesley
- The Vascular Care Group - Worcester
Connecticut
- Vascular Care Connecticut - Darien
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-06-14 |
| Est. Completion | 2026-07 |
What the registry record for NCT05928221 still lists
NCT05928221 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 1 condition, with Acute Deep Venous Thrombosis of Ileofemoral Vein appearing as the primary indexed condition, and to 1 intervention - of which Thrombectomy is the first listed.
NCT05928221 lists 6 locations in 2 states (Massachusetts, Connecticut).
Frequently Asked Questions
What is clinical trial NCT05928221 about?
NCT05928221 is a clinical study titled "Post Market Registry Study of the Philips QuickClear Mechanical Thrombectomy System". A post-market study of the QuickClear Mechanical Thrombectomy system used for the removal of acute Deep Vein Thrombosis (DVT) from the deep veins of legs in the setting of an office interventional suite.
What is the current status of trial NCT05928221?
This trial is currently active not recruiting. The enrollment target is 50 participants. The study started on 2023-06-14. Estimated completion is 2026-07.
What conditions does trial NCT05928221 study?
This clinical trial studies the following conditions: Acute Deep Venous Thrombosis of Ileofemoral Vein.
What interventions are being tested in trial NCT05928221?
The interventions under investigation include: Thrombectomy (DEVICE).
Who is sponsoring clinical trial NCT05928221?
This trial is sponsored by Paul J. Gagne, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05928221 being conducted?
This trial has 6 study locations across Connecticut, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI